• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Civco acquires maker of positioning devices

Article

Medical instruments provider Civco has completed the acquisition of Barzell-Whitmore Maroon Bells, a designer and manufacturer of specialized positioning and stabilizing devices used in image-guided minimally invasive surgery. The

Medical instruments provider Civco has completed the acquisition of Barzell-Whitmore Maroon Bells, a designer and manufacturer of specialized positioning and stabilizing devices used in image-guided minimally invasive surgery. The subsidiary of Colorado MedTech made the purchase with 127,000 shares of MedTech stock and $2 million in cash at closing. An additional $2.2 million will be paid if certain performance standards are met. Annualized revenues associated with the acquisition are expected to be about $2 million. Barzell-Whitmore's devices are used in evaluation of colorectal disease and the treatment of prostate cancer. Expected future applications will involve laparoscopic surgery and the treatment of benign prostate hyperplasia. The acquisition will expand the portfolio of Civco products used to perform image-guided procedures.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.